ABBOTT LABORATORIES — Director's Dealing 2009

Nov 20, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2009-11-18

Reporting Person: Fussell Stephen R (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-11-18	Common shares without par value	M	5321	$48.33	Acquired	123321	Direct
2009-11-18	Common shares without par value	M	6597	$43.00	Acquired	129918	Direct
2009-11-18	Common shares without par value	M	1442	$47.82	Acquired	131360	Direct
2009-11-18	Common shares without par value	M	1532	$32.6111	Acquired	132892	Direct
2009-11-18	Common shares without par value	S	14892	$53.00	Disposed	118000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-11-18	Option (right to buy)	$48.33	M	5321	Disposed	2010-02-10	Common shares (5321)	Direct
2009-11-18	Option (right to buy)	$43.00	M	6597	Disposed	2010-02-10	Common shares (6597)	Direct
2009-11-18	Option (right to buy)	$47.82	M	1442	Disposed	2010-02-10	Common shares (1442)	Direct
2009-11-18	Option (right to buy)	$32.6111	M	1532	Disposed	2010-02-10	Common shares (1532)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	786	Indirect

Footnotes

F1: Amount is subject to adjustment pursuant to a domestic relations order.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of November 18, 2009.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.